Autopsy report · NCT02031536
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Cause of deathSlow enrollment
“Slow accrual”
Life of this trial
- Registered 3 months before it started.
- Ran for about 3 years 3 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 3 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Sponsor type
- University, hospital or other
- Conditions
- Gastrinoma; Glucagonoma; Insulinoma; Liver Metastases; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma
- Interventions
- everolimus; placebo
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.